Serotonin receptors and their function in sleep, anxiety disorders and depression

被引:69
作者
Leonard, BE
机构
[1] Pharmacology Department, University College, Galway
关键词
serotonin; receptor sub-types; sleep; anxiety disorder; depression; schizophrenia;
D O I
10.1159/000289049
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Thirty-three years ago, Gaddum and Picarelli classified the serotonin receptors in the guinea pig ileum into D and M types based on the activity of dibenzyline (D) and morphine (M) to block contractions of intestinal smooth muscle caused by serotonin. The subsequent location of specific ligand binding sites for serotonin in the brain has led to the identification of 14 serotonin receptor sub-types in rat brain. The cloning of these receptor sub-types has been of importance in enabling them to be classified as specific-protein molecules encoded by specific genes. The problem now arises with regard to the linking of the changes in the cellular activity of the various receptor sub-types with the plethora of behavioural changes that arise as a consequence of the actions of serotonin in the brain. The present review summarizes the evidence implicating the role of specific serotonin receptor sub-types in sleep, anxiety states, schizophrenia and depression. A summary of the relationship between these receptor sub-types and their possible involvement in the aetiology of schizophrenia, depression, anxiety and sleep disorders.
引用
收藏
页码:66 / 75
页数:10
相关论文
共 71 条
[2]   THE DISTRIBUTION OF SUBSTANCE-P AND 5-HYDROXYTRYPTAMINE IN THE CENTRAL NERVOUS SYSTEM OF THE DOG [J].
AMIN, AH ;
CRAWFORD, TBB ;
GADDUM, JH .
JOURNAL OF PHYSIOLOGY-LONDON, 1954, 126 (03) :596-618
[3]  
ARORA RC, 1989, AM J PSYCHIAT, V146, P730
[4]  
BAXTER LR, 1987, PSYCHOPATHOLOGY, V20, P114
[5]   THE 5-HT4 RECEPTOR - A PLACE IN THE SUN [J].
BOCKAERT, J ;
FOZARD, JR ;
DUMUIS, A ;
CLARKE, DE .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (04) :141-145
[6]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[7]   THE CHRONIC EFFECTS OF DESIPRAMINE AND SERTRALINE ON PLATELET AND SYNAPTOSOMAL 5HT UPTAKE IN OLFACTORY BULBECTOMIZED RATS [J].
BUTLER, J ;
TANNIAN, M ;
LEONARD, BE .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (05) :585-594
[8]  
BUTLER J, 1988, PROGR CATECHOLAMIN C, P399
[9]   DIFFERENTIAL INHIBITORY EFFECTS OF A 5-HT3 ANTAGONIST ON DRUG-INDUCED STIMULATION OF DOPAMINE RELEASE [J].
CARBONI, E ;
ACQUAS, E ;
FRAU, R ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (03) :515-519
[10]   THE INFLUENCE OF RITANSERIN, A SEROTONIN ANTAGONIST, IN ANXIETY DISORDERS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY VERSUS LORAZEPAM [J].
CEULEMANS, DLS ;
HOPPENBROUWERS, MLJA ;
GELDERS, YG ;
REYNTJENS, AJM .
PHARMACOPSYCHIATRY, 1985, 18 (05) :303-305